Login Register Cart 0
Review Article

人血小板非编码RNA在心血管疾病中的作用

卷 29, 期 19, 2022

发表于: 03 February, 2022

页: [3420 - 3444] 页: 25

弟呕挨: 10.2174/0929867329666211230104955

价格: $65

摘要

心血管疾病(CVD)是世界上主要的死亡原因。近年来，已经开展了大量涉及转录组学方法的遗传学研究，旨在详细了解该疾病和开发新的治疗策略。对血小板的研究越来越多，因为血小板与CVD有关，因为它们能够释放影响各种途径的调节分子。血小板向血浆分泌超过500种不同的分子，包括大量的非编码(nc)RNA(miRNA、lncRNA或circRNA)。这些ncRNA对应于98%的未被翻译成蛋白质的转录本，因为它们在生理和疾病中是重要的调节因子。因此，miRNAs可以通过碱基配对相互作用将蛋白质复合物引导到mRNA，从而导致翻译阻断或/和转录降解。这些lncRNA通过与转录因子结合，通过不同的机制发挥作用。最后，环状RNA作为miRNA的调节因子，干扰其作用。血小板分泌的ncRNA的曲目和/或数量的改变可以触发CVD和其他疾病。ncRNA可以作为疾病的有效生物标志物，或由于其参与疾病而作为治疗靶点。在这篇综述中，我们将重点讨论由血小板分泌的最重要的ncRNA(9miRNA，9lncRNA和5circRNA)，它们与CVD的关系，以及这些ncRNA对CVD风险的贡献，以更好地理解人血小板ncRNA与CVD之间的关系。

关键词: 心血管疾病，miRNA，lncRNA，环状cRNA，血小板，环状RNA。

« Previous Next »
[1]
Roth, G.A.; Mensah, G.A.; Johnson, C.O.; Addolorato, G.; Ammirati, E.; Baddour, L.M.; Barengo, N.C.; Beaton, A.Z.; Benjamin, E.J.; Benziger, C.P.; Bonny, A.; Brauer, M.; Brodmann, M.; Cahill, T.J.; Carapetis, J.; Catapano, A.L.; Chugh, S.S.; Cooper, L.T.; Coresh, J.; Criqui, M.; DeCleene, N.; Eagle, K.A.; Emmons-Bell, S.; Feigin, V.L.; Fernández-Solà, J.; Fowkes, G.; Gakidou, E.; Grundy, S.M.; He, F.J.; Howard, G.; Hu, F.; Inker, L.; Karthikeyan, G.; Kassebaum, N.; Koroshetz, W.; Lavie, C.; Lloyd-Jones, D.; Lu, H.S.; Mirijello, A.; Temesgen, A.M.; Mokdad, A.; Moran, A.E.; Muntner, P.; Narula, J.; Neal, B.; Ntsekhe, M.; Moraes de Oliveira, G.; Otto, C.; Owolabi, M.; Pratt, M.; Rajagopalan, S.; Reitsma, M.; Ribeiro, A.L.P.; Rigotti, N.; Rodgers, A.; Sable, C.; Shakil, S.; Sliwa-Hahnle, K.; Stark, B.; Sundström, J.; Timpel, P.; Tleyjeh, I.M.; Valgimigli, M.; Vos, T.; Whelton, P.K.; Yacoub, M.; Zuhlke, L.; Murray, C.; Fuster, V. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J. Am. Coll. Cardiol., 2020, 76(25), 2982-3021.
[http://dx.doi.org/10.1016/j.jacc.2020.11.010] [PMID: 33309175]
[2]
de Gonzalo-Calvo, D.; Vea, A.; Bär, C.; Fiedler, J.; Couch, L.S.; Brotons, C.; Llorente-Cortes, V.; Thum, T. Circulating non-coding RNAs in biomarker-guided cardiovascular therapy: A novel tool for personalized medicine? Eur. Heart J., 2019, 40(20), 1643-1650.
[http://dx.doi.org/10.1093/eurheartj/ehy234] [PMID: 29688487]
[3]
Lu, D.; Thum, T. RNA-based diagnostic and therapeutic strategies for cardiovascular disease. Nat. Rev. Cardiol., 2019, 16(11), 661-674.
[http://dx.doi.org/10.1038/s41569-019-0218-x] [PMID: 31186539]
[4]
Papapanagiotou, A.; Daskalakis, G.; Siasos, G.; Gargalionis, A.; Papavassiliou, A.G. The role of platelets in cardiovascular disease: Molecular mechanisms. Curr. Pharm. Des., 2016, 22(29), 4493-4505.
[http://dx.doi.org/10.2174/1381612822666160607064118] [PMID: 27281334]
[5]
Nassa, G.; Giurato, G.; Cimmino, G.; Rizzo, F.; Ravo, M.; Salvati, A.; Nyman, T.A.; Zhu, Y.; Vesterlund, M.; Lehtiö, J.; Golino, P.; Weisz, A.; Tarallo, R. Splicing of platelet resident pre-mRNAs upon activation by physiological stimuli results in functionally relevant proteome modifications. Sci. Rep., 2018, 8(1), 498.
[http://dx.doi.org/10.1038/s41598-017-18985-5] [PMID: 29323256]
[6]
Osman, A.; Hitzler, W.E.; Ameur, A.; Provost, P. Differential expression analysis by RNA-Seq reveals perturbations in the platelet mRNA transcriptome triggered by pathogen reduction systems. PLoS One, 2015, 10(7), e0133070.
[http://dx.doi.org/10.1371/journal.pone.0133070] [PMID: 26172280]
[7]
Rowley, J.W.; Oler, A.J.; Tolley, N.D.; Hunter, B.N.; Low, E.N.; Nix, D.A.; Yost, C.C.; Zimmerman, G.A.; Weyrich, A.S. Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood, 2011, 118(14), e101-e111.
[http://dx.doi.org/10.1182/blood-2011-03-339705] [PMID: 21596849]
[8]
Provost, P. The clinical significance of platelet microparticle-associated microRNAs. Clin. Chem. Lab. Med., 2017, 55(5), 657-666. [CCLM].
[http://dx.doi.org/10.1515/cclm-2016-0895] [PMID: 28099120]
[9]
Rowley, J.; Weyrich, A.; Bray, P. The platelet transcriptome in health and disease. Platelet, 2019, 139-153.
[http://dx.doi.org/10.1016/B978-0-12-813456-6.00007-2]
[10]
Clancy, L.; Freedman, J.E. The role of circulating platelet transcripts. J. Thromb. Haemost., 2015, 13(S1)(Suppl. 1), S33-S39.
[http://dx.doi.org/10.1111/jth.12922] [PMID: 26149043]
[11]
Xia, L.; Zeng, Z.; Tang, W.H. The role of platelet microparticle associated microRNAs in cellular crosstalk. Front. Cardiovasc. Med., 2018, 5, 29.
[http://dx.doi.org/10.3389/fcvm.2018.00029] [PMID: 29670887]
[12]
Ghafouri-Fard, S.; Esmaeili, M.; Taheri, M. Expression of non-coding RNAs in hematological malignancies. Eur. J. Pharmacol., 2020, 875, 172976.
[http://dx.doi.org/10.1016/j.ejphar.2020.172976] [PMID: 32112777]
[13]
Cao, Q.; Wu, J.; Wang, X.; Song, C. Noncoding RNAs in vascular aging. Oxid. Med. Cell. Longev., 2020, 2020, 7914957.
[http://dx.doi.org/10.1155/2020/7914957] [PMID: 31998442]
[14]
Peters, M.M.C.; Sampaio-Pinto, V.; da Costa Martins, P.A. Non-coding RNAs in endothelial cell signalling and hypoxia during cardiac regeneration. Biochim. Biophys. Acta Mol. Cell Res., 2020, 1867(3), 118515.
[http://dx.doi.org/10.1016/j.bbamcr.2019.07.010] [PMID: 31362011]
[15]
Kung, J.T.Y.; Colognori, D.; Lee, J.T. Long noncoding RNAs: Past, present, and future. Genetics, 2013, 193(3), 651-669.
[http://dx.doi.org/10.1534/genetics.112.146704] [PMID: 23463798]
[16]
Carneiro FD, Almeida KCd, Fernandes-Santos C. Role of miRNAs on the pathophysiology of cardiovascular diseases. Arq. Bras. Cardiol., 2018, 111, 738-746.
[17]
O’Brien, J.; Hayder, H.; Zayed, Y.; Peng, C. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front. Endocrinol. (Lausanne), 2018, 9(402), 402.
[http://dx.doi.org/10.3389/fendo.2018.00402] [PMID: 30123182]
[18]
Djuranovic, S.; Nahvi, A.; Green, R. miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science, 2012, 336(6078), 237-240.
[http://dx.doi.org/10.1126/science.1215691] [PMID: 22499947]
[19]
Bhaskaran, M.; Mohan, M. MicroRNAs: History, biogenesis, and their evolving role in animal development and disease. Vet. Pathol., 2014, 51(4), 759-774.
[http://dx.doi.org/10.1177/0300985813502820] [PMID: 24045890]
[20]
García-López, J.; Brieño-Enríquez, M.A.; Del Mazo, J. MicroRNA biogenesis and variability. Biomol. Concepts, 2013, 4(4), 367-380.
[http://dx.doi.org/10.1515/bmc-2013-0015] [PMID: 25436586]
[21]
Hembrom, A.A.; Srivastava, S.; Garg, I.; Kumar, B. MicroRNAs in venous thrombo-embolism. Clin. Chim. Acta, 2020, 504, 66-72.
[http://dx.doi.org/10.1016/j.cca.2020.01.034] [PMID: 32017924]
[22]
Bhatlekar, S.; Manne, B.K.; Basak, I.; Edelstein, L.C.; Tugolukova, E.; Stoller, M.L.; Cody, M.J.; Morley, S.C.; Nagalla, S.; Weyrich, A.S.; Rowley, J.W.; O’Connell, R.M.; Rondina, M.T.; Campbell, R.A.; Bray, P.F. miR-125a-5p regulates megakaryocyte proplatelet formation via the actin-bundling protein L-plastin. Blood, 2020, 136(15), 1760-1772.
[http://dx.doi.org/10.1182/blood.2020005230] [PMID: 32844999]
[23]
Ruan, X.; Li, P.; Chen, Y.; Shi, Y.; Pirooznia, M.; Seifuddin, F.; Suemizu, H.; Ohnishi, Y.; Yoneda, N.; Nishiwaki, M.; Shepherdson, J.; Suresh, A.; Singh, K.; Ma, Y.; Jiang, C.F.; Cao, H. In vivo functional analysis of non-conserved human lncRNAs associated with cardiometabolic traits. Nat. Commun., 2020, 11(1), 45.
[http://dx.doi.org/10.1038/s41467-019-13688-z] [PMID: 31896749]
[24]
Lin, L.; Li, Q.; Hao, W.; Zhang, Y.; Zhao, L.; Han, W. Upregulation of LncRNA malat1 induced proliferation and migration of airway smooth muscle cells via miR-150-eIF4E/Akt signaling. Front. Physiol., 2019, 10, 1337.
[http://dx.doi.org/10.3389/fphys.2019.01337] [PMID: 31695627]
[25]
Dahariya, S.; Paddibhatla, I.; Kumar, S.; Raghuwanshi, S.; Pallepati, A.; Gutti, R.K. Long non-coding RNA: Classification, biogenesis and functions in blood cells. Mol. Immunol., 2019, 112, 82-92.
[http://dx.doi.org/10.1016/j.molimm.2019.04.011] [PMID: 31079005]
[26]
Ma, L.; Bajic, V.B.; Zhang, Z. On the classification of long non-coding RNAs. RNA Biol., 2013, 10(6), 925-933.
[http://dx.doi.org/10.4161/rna.24604] [PMID: 23696037]
[27]
Zhang, P.; Wu, W.; Chen, Q.; Chen, M. Non-Coding RNAs and their integrated networks. J. Integr. Bioinform., 2019, 16(3), 20190027.
[http://dx.doi.org/10.1515/jib-2019-0027] [PMID: 31301674]
[28]
Shen, E.; Zhu, X.; Hua, S.; Chen, H.; Ye, C.; Zhou, L.; Liu, Q.; Zhu, Q.H.; Fan, L.; Chen, X. Genome-wide identification of oil biosynthesis-related long non-coding RNAs in allopolyploid Brassica napus. BMC Genomics, 2018, 19(1), 745.
[http://dx.doi.org/10.1186/s12864-018-5117-8] [PMID: 30314449]
[29]
Ma, X.; Zhang, X.; Traore, S.M.; Xin, Z.; Ning, L.; Li, K.; Zhao, K.; Li, Z.; He, G.; Yin, D. Genome-wide identification and analysis of long noncoding RNAs (lncRNAs) during seed development in peanut (Arachis hypogaea L.). BMC Plant Biol., 2020, 20(1), 192.
[http://dx.doi.org/10.1186/s12870-020-02405-4] [PMID: 32375650]
[30]
Yao, P.; Li, Y-L.; Chen, Y.; Shen, W.; Wu, K-Y.; Xu, W.H. Overexpression of long non-coding RNA Rian attenuates cell apoptosis from cerebral ischemia-reperfusion injury via Rian/miR-144-3p/GATA3 signaling. Gene, 2020, 737, 144411.
[http://dx.doi.org/10.1016/j.gene.2020.144411] [PMID: 32006596]
[31]
Li, G-J.; Ding, H.; Miao, D. Long-noncoding RNA HOTAIR inhibits immunologic rejection of mouse leukemia cells through activating the Wnt/β-catenin signaling pathway in a mouse model of leukemia. J. Cell. Physiol., 2019, 234(7), 10386-10396.
[http://dx.doi.org/10.1002/jcp.27705] [PMID: 30609034]
[32]
Kumar, L.; Shamsuzzama, .; Haque, R.; Baghel, T.; Nazir, A. Circular RNAs: the emerging class of non-coding RNAs and their potential role in human neurodegenerative diseases. Mol. Neurobiol., 2017, 54(9), 7224-7234.
[http://dx.doi.org/10.1007/s12035-016-0213-8] [PMID: 27796758]
[33]
Greene, J.; Baird, A-M.; Brady, L.; Lim, M.; Gray, S.G.; McDermott, R.; Finn, S.P. Circular RNAs: Biogenesis, function and role in human diseases. Front. Mol. Biosci., 2017, 4, 38.
[http://dx.doi.org/10.3389/fmolb.2017.00038] [PMID: 28634583]
[34]
Devaux, Y.; Creemers, E.E.; Boon, R.A.; Werfel, S.; Thum, T.; Engelhardt, S.; Dimmeler, S.; Squire, I. Circular RNAs in heart failure. Eur. J. Heart Fail., 2017, 19(6), 701-709.
[http://dx.doi.org/10.1002/ejhf.801] [PMID: 28345158]
[35]
Jamal, M.; Song, T.; Chen, B.; Faisal, M.; Hong, Z.; Xie, T.; Wu, Y.; Pan, S.; Yin, Q.; Shao, L.; Zhang, Q. Recent progress on circular RNA research in acute myeloid leukemia. Front. Oncol., 2019, 9, 1108.
[http://dx.doi.org/10.3389/fonc.2019.01108] [PMID: 31781482]
[36]
Vromman, M.; Vandesompele, J.; Volders, P-J. Closing the circle: Current state and perspectives of circular RNA databases. Brief. Bioinform., 2021, 22(1), 288-297.
[PMID: 31998941]
[37]
Nicolet, B.P.; Engels, S.; Aglialoro, F.; van den Akker, E.; von Lindern, M.; Wolkers, M.C. Circular RNA expression in human hematopoietic cells is widespread and cell-type specific. Nucleic Acids Res., 2018, 46(16), 8168-8180.
[http://dx.doi.org/10.1093/nar/gky721] [PMID: 30124921]
[38]
Huang, S.; Yang, B.; Chen, B.J.; Bliim, N.; Ueberham, U.; Arendt, T.; Janitz, M. The emerging role of circular RNAs in transcriptome regulation. Genomics, 2017, 109(5-6), 401-407.
[http://dx.doi.org/10.1016/j.ygeno.2017.06.005] [PMID: 28655641]
[39]
Huang, A.; Zheng, H.; Wu, Z.; Chen, M.; Huang, Y. Circular RNA-protein interactions: Functions, mechanisms, and identification. Theranostics, 2020, 10(8), 3503-3517.
[http://dx.doi.org/10.7150/thno.42174] [PMID: 32206104]
[40]
Fan, X.; Weng, X.; Zhao, Y.; Chen, W.; Gan, T.; Xu, D. Circular RNAs in cardiovascular disease: An overview. BioMed Res. Int., 2017, 2017, 5135781.
[http://dx.doi.org/10.1155/2017/5135781] [PMID: 28210621]
[41]
Burnouf, T.; Goubran, H.A.; Chou, M-L.; Devos, D.; Radosevic, M. Platelet microparticles: Detection and assessment of their paradoxical functional roles in disease and regenerative medicine. Blood Rev., 2014, 28(4), 155-166.
[http://dx.doi.org/10.1016/j.blre.2014.04.002] [PMID: 24826991]
[42]
Pordzik, J.; Pisarz, K.; De Rosa, S.; Jones, A.D.; Eyileten, C.; Indolfi, C.; Malek, L.; Postula, M. The potential role of platelet-related microRNAs in the development of cardiovascular events in high-risk populations, including diabetic patients: A review. Front. Endocrinol. (Lausanne), 2018, 9, 74.
[http://dx.doi.org/10.3389/fendo.2018.00074] [PMID: 29615970]
[43]
Espinosa-Parrilla, Y.; Gonzalez-Billault, C.; Fuentes, E.; Palomo, I.; Alarcón, M. Decoding the role of platelets and related microRNAs in aging and neurodegenerative disorders. Front. Aging Neurosci., 2019, 11, 151.
[http://dx.doi.org/10.3389/fnagi.2019.00151] [PMID: 31312134]
[44]
Fuentes, E.; Palomo, I.; Alarcón, M. Platelet miRNAs and cardiovascular diseases. Life Sci., 2015, 133, 29-44.
[http://dx.doi.org/10.1016/j.lfs.2015.04.016] [PMID: 26003375]
[45]
Best, M.G.; Sol, N.; Kooi, I.; Tannous, J.; Westerman, B.A.; Rustenburg, F.; Schellen, P.; Verschueren, H.; Post, E.; Koster, J.; Ylstra, B.; Ameziane, N.; Dorsman, J.; Smit, E.F.; Verheul, H.M.; Noske, D.P.; Reijneveld, J.C.; Nilsson, R.J.A.; Tannous, B.A.; Wesseling, P.; Wurdinger, T. RNA-Seq of tumor-educated platelets enables blood-based pan-cancer, multiclass, and molecular pathway cancer diagnostics. Cancer Cell, 2015, 28(5), 666-676.
[http://dx.doi.org/10.1016/j.ccell.2015.09.018] [PMID: 26525104]
[46]
Shi, R.; Zhou, X.; Ji, W-J.; Zhang, Y-Y.; Ma, Y-Q.; Zhang, J-Q.; Li, Y.M. The emerging role of miR-223 in platelet reactivity: implications in antiplatelet therapy. BioMed Res. Int., 2015, 2015, 981841.
[http://dx.doi.org/10.1155/2015/981841] [PMID: 26221610]
[47]
Chen, Z.; Li, C.; Lin, K.; Zhang, Q.; Chen, Y.; Rao, L. MicroRNAs in acute myocardial infarction: Evident value as novel biomarkers? Anatol. J. Cardiol., 2018, 19(2), 140-147.
[http://dx.doi.org/10.14744/AnatolJCardiol.2017.8124] [PMID: 29424735]
[48]
Zampetaki, A.; Willeit, P.; Tilling, L.; Drozdov, I.; Prokopi, M.; Renard, J-M.; Mayr, A.; Weger, S.; Schett, G.; Shah, A.; Boulanger, C.M.; Willeit, J.; Chowienczyk, P.J.; Kiechl, S.; Mayr, M. Prospective study on circulating MicroRNAs and risk of myocardial infarction. J. Am. Coll. Cardiol., 2012, 60(4), 290-299.
[http://dx.doi.org/10.1016/j.jacc.2012.03.056] [PMID: 22813605]
[49]
Schulte, C.; Molz, S.; Appelbaum, S.; Karakas, M.; Ojeda, F.; Lau, D.M.; Hartmann, T.; Lackner, K.J.; Westermann, D.; Schnabel, R.B.; Blankenberg, S.; Zeller, T. miRNA-197 and miRNA-223 predict cardiovascular death in a cohort of patients with symptomatic coronary artery disease. PLoS One, 2015, 10(12), e0145930.
[http://dx.doi.org/10.1371/journal.pone.0145930] [PMID: 26720041]
[50]
Zhang, Z.; Qiao, G.; Sun, Z.; Chen, X.; Liu, J.; Lu, W. Expression of miR-223-3p in a rat model of myocardial infarction and the effects of miR-223-3p on cardiomyocytes. All Life, 2020, 13(1), 407-415.
[http://dx.doi.org/10.1080/26895293.2020.1796827]
[51]
Rangrez, A.Y.; Kumari, M.; Frey, N. An emerging role of microRNA miR-223 in cardiovascular pathophysiology. microRNAs Cardiovasc. Res., 2013, 1, 23-33.
[52]
Zampetaki, A.; Kiechl, S.; Drozdov, I.; Willeit, P.; Mayr, U.; Prokopi, M.; Mayr, A.; Weger, S.; Oberhollenzer, F.; Bonora, E.; Shah, A.; Willeit, J.; Mayr, M. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ. Res., 2010, 107(6), 810-817.
[http://dx.doi.org/10.1161/CIRCRESAHA.110.226357] [PMID: 20651284]
[53]
Carino, A.; De Rosa, S.; Sorrentino, S.; Polimeni, A.; Sabatino, J.; Caiazzo, G.; Torella, D.; Spaccarotella, C.; Mongiardo, A.; Strangio, A.; Filippis, C.; Indolfi, C. Modulation of circulating MicroRNAs levels during the switch from clopidogrel to ticagrelor. BioMed Res. Int., 2016, 2016, 3968206.
[http://dx.doi.org/10.1155/2016/3968206] [PMID: 27366745]
[54]
Zapilko, V.; Fish, R.J.; Garcia, A.; Reny, J-L.; Dunoyer-Geindre, S.; Lecompte, T.; Neerman-Arbez, M.; Fontana, P. MicroRNA-126 is a regulator of platelet-supported thrombin generation. Platelets, 2020, 31(6), 746-755.
[http://dx.doi.org/10.1080/09537104.2020.1775804] [PMID: 32529909]
[55]
Meng, Q.; Wang, W.; Yu, X.; Li, W.; Kong, L.; Qian, A.; Li, C.; Li, X. Upregulation of microRNA-126 contributes to endothelial progenitor cell function in deep vein thrombosis via its target PIK3R2. J. Cell. Biochem., 2015, 116(8), 1613-1623.
[http://dx.doi.org/10.1002/jcb.25115] [PMID: 25652288]
[56]
Karolina, D.S.; Tavintharan, S.; Armugam, A.; Sepramaniam, S.; Pek, S.L.T.; Wong, M.T.K.; Lim, S.C.; Sum, C.F.; Jeyaseelan, K. Circulating miRNA profiles in patients with metabolic syndrome. J. Clin. Endocrinol. Metab., 2012, 97(12), E2271-E2276.
[http://dx.doi.org/10.1210/jc.2012-1996] [PMID: 23032062]
[57]
Li, J.; Sun, H.; Liu, T.; Kong, J. MicroRNA-423 promotes proliferation, migration and invasion and induces chemoresistance of endometrial cancer cells. Exp. Ther. Med., 2018, 16(5), 4213-4224.
[http://dx.doi.org/10.3892/etm.2018.6710] [PMID: 30344696]
[58]
Fan, K-L.; Zhang, H-F.; Shen, J.; Zhang, Q.; Li, X-L. Circulating microRNAs levels in Chinese heart failure patients caused by dilated cardiomyopathy. Indian Heart J., 2013, 65(1), 12-16.
[http://dx.doi.org/10.1016/j.ihj.2012.12.022] [PMID: 23438607]
[59]
Yan, H.; Ma, F.; Zhang, Y.; Wang, C.; Qiu, D.; Zhou, K. miRNAs as biomarkers for diagnosis of heart failure: A systematic review and meta-analysis. Medicine (Baltimore), 2017, 96(22), e6825.
[60]
Luo, P.; He, T.; Jiang, R.; Li, G. MicroRNA-423-5p targets O-GlcNAc transferase to induce apoptosis in cardiomyocytes. Mol. Med. Rep., 2015, 12(1), 1163-1168.
[http://dx.doi.org/10.3892/mmr.2015.3491] [PMID: 25776937]
[61]
Jäntti, T.; Segersvärd, H.; Tolppanen, H.; Tarvasmäki, T.; Lassus, J.; Devaux, Y.; Vausort, M.; Pulkki, K.; Sionis, A.; Bayes-Genis, A.; Tikkanen, I.; Lakkisto, P.; Harjola, V.P. Circulating levels of microRNA 423-5p are associated with 90 day mortality in cardiogenic shock. ESC Heart Fail., 2019, 6(1), 98-102.
[http://dx.doi.org/10.1002/ehf2.12377] [PMID: 30472788]
[62]
Liu, K.; Wang, L.; Sun, E. Prognostic value of miR-221 in human malignancy: Evidence from 3041 subjects. BMC Cancer, 2019, 19(1), 867.
[http://dx.doi.org/10.1186/s12885-019-6079-1] [PMID: 31470827]
[63]
Plé, H.; Landry, P.; Benham, A.; Coarfa, C.; Gunaratne, P.H.; Provost, P. The repertoire and features of human platelet microRNAs. PLoS One, 2012, 7(12), e50746.
[http://dx.doi.org/10.1371/journal.pone.0050746] [PMID: 23226537]
[64]
Peng, L.; Liu, J.; Qin, L.; Liu, J.; Xi, S.; Lu, C.; Yin, T. Interaction between platelet-derived microRNAs and CYP2C19*2 genotype on clopidogrel antiplatelet responsiveness in patients with ACS. Thromb. Res., 2017, 157, 97-102.
[http://dx.doi.org/10.1016/j.thromres.2017.07.011] [PMID: 28734158]
[65]
Tham, Y.K.; Bernardo, B.C.; Ooi, J.Y.Y.; Weeks, K.L.; McMullen, J.R. Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets. Arch. Toxicol., 2015, 89(9), 1401-1438.
[http://dx.doi.org/10.1007/s00204-015-1477-x] [PMID: 25708889]
[66]
Wang, C.; Wang, S.; Zhao, P.; Wang, X.; Wang, J.; Wang, Y.; Song, L.; Zou, Y.; Hui, R. MiR-221 promotes cardiac hypertrophy in vitro through the modulation of p27 expression. J. Cell. Biochem., 2012, 113(6), 2040-2046.
[http://dx.doi.org/10.1002/jcb.24075] [PMID: 22275134]
[67]
Kuosmanen, S.M.; Hartikainen, J.; Hippeläinen, M.; Kokki, H.; Levonen, A-L.; Tavi, P. MicroRNA profiling of pericardial fluid samples from patients with heart failure. PLoS One, 2015, 10(3), e0119646.
[http://dx.doi.org/10.1371/journal.pone.0119646] [PMID: 25763857]
[68]
Barwari, T.; Eminaga, S.; Mayr, U.; Lu, R.; Armstrong, P.C.; Chan, M.V.; Sahraei, M.; Fernández-Fuertes, M.; Moreau, T.; Barallobre-Barreiro, J.; Lynch, M.; Yin, X.; Schulte, C.; Baig, F.; Pechlaner, R.; Langley, S.R.; Zampetaki, A.; Santer, P.; Weger, M.; Plasenzotti, R.; Schosserer, M.; Grillari, J.; Kiechl, S.; Willeit, J.; Shah, A.M.; Ghevaert, C.; Warner, T.D.; Fernández-Hernando, C.; Suárez, Y.; Mayr, M. Inhibition of profibrotic microRNA-21 affects platelets and their releasate. JCI Insight, 2018, 3(21), 123335.
[http://dx.doi.org/10.1172/jci.insight.123335] [PMID: 30385722]
[69]
Chen, C-H.; Hsu, S-Y.; Chiu, C-C.; Leu, S. MicroRNA-21 mediates the protective effect of cardiomyocyte-derived conditioned medium on ameliorating myocardial infarction in rats. Cells, 2019, 8(8), 935.
[http://dx.doi.org/10.3390/cells8080935] [PMID: 31430983]
[70]
Cheng, Y.; Zhang, C. MicroRNA-21 in cardiovascular disease. J. Cardiovasc. Transl. Res., 2010, 3(3), 251-255.
[http://dx.doi.org/10.1007/s12265-010-9169-7] [PMID: 20560046]
[71]
Bonci, D. MicroRNA-21 as therapeutic target in cancer and cardiovascular disease. Recent Patents Cardiovasc. Drug Discov. (Discont.), 2010, 5(3), 156-161.
[http://dx.doi.org/10.2174/157489010793351962] [PMID: 20649511]
[72]
Yuan, J.; Chen, H.; Ge, D.; Xu, Y.; Xu, H.; Yang, Y.; Gu, M.; Zhou, Y.; Zhu, J.; Ge, T.; Chen, Q.; Gao, Y.; Wang, Y.; Li, X.; Zhao, Y. Mir-21 promotes cardiac fibrosis after myocardial infarction via targeting Smad7. Cell. Physiol. Biochem., 2017, 42(6), 2207-2219.
[http://dx.doi.org/10.1159/000479995] [PMID: 28817807]
[73]
Huang, C-K.; Bär, C.; Thum, T. miR-21, mediator, and potential therapeutic target in the cardiorenal syndrome. Front. Pharmacol., 2020, 11, 726.
[http://dx.doi.org/10.3389/fphar.2020.00726] [PMID: 32499708]
[74]
Li, F.; Xu, Y.; Deng, S.; Li, Z.; Zou, D.; Yi, S.; Sui, W.; Hao, M.; Qiu, L. MicroRNA-15a/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma. Oncotarget, 2015, 6(35), 38270-38282.
[http://dx.doi.org/10.18632/oncotarget.5681] [PMID: 26516702]
[75]
Osman, A.; Fälker, K. Characterization of human platelet microRNA by quantitative PCR coupled with an annotation network for predicted target genes. Platelets, 2011, 22(6), 433-441.
[http://dx.doi.org/10.3109/09537104.2011.560305] [PMID: 21438667]
[76]
Rink, C.; Khanna, S. MicroRNA in ischemic stroke etiology and pathology. Physiol. Genomics, 2011, 43(10), 521-528.
[http://dx.doi.org/10.1152/physiolgenomics.00158.2010] [PMID: 20841499]
[77]
Li, G.; Morris-Blanco, K.C.; Lopez, M.S.; Yang, T.; Zhao, H.; Vemuganti, R.; Luo, Y. Impact of microRNAs on ischemic stroke: From pre- to post-disease. Prog. Neurobiol., 2018, 163-164, 59-78.
[http://dx.doi.org/10.1016/j.pneurobio.2017.08.002] [PMID: 28842356]
[78]
Gimbrone, M.A.Jr.; García-Cardeña, G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ. Res., 2016, 118(4), 620-636.
[http://dx.doi.org/10.1161/CIRCRESAHA.115.306301] [PMID: 26892962]
[79]
Lu, W.J.; Zeng, L.L.; Wang, Y.; Zhang, Y.; Liang, H.B.; Tu, X.Q.; He, J.R.; Yang, G.Y. Blood microRNA-15a correlates with IL-6, IGF-1 and acute cerebral ischemia. Curr. Neurovasc. Res., 2018, 15(1), 63-71.
[http://dx.doi.org/10.2174/1567202615666180319143509] [PMID: 29557747]
[80]
Yang, X.; Tang, X.; Sun, P.; Shi, Y.; Liu, K.; Hassan, S.H.; Stetler, R.A.; Chen, J.; Yin, K.J. MicroRNA-15a/16-1 antagomir ameliorates ischemic brain injury in experimental stroke. Stroke, 2017, 48(7), 1941-1947.
[http://dx.doi.org/10.1161/STROKEAHA.117.017284] [PMID: 28546328]
[81]
Nishi, M.; Eguchi-Ishimae, M.; Wu, Z.; Gao, W.; Iwabuki, H.; Kawakami, S.; Tauchi, H.; Inukai, T.; Sugita, K.; Hamasaki, Y.; Ishii, E.; Eguchi, M. Suppression of the let-7b microRNA pathway by DNA hypermethylation in infant acute lymphoblastic leukemia with MLL gene rearrangements. Leukemia, 2013, 27(2), 389-397.
[http://dx.doi.org/10.1038/leu.2012.242] [PMID: 22918121]
[82]
Yan, H.; Fang, M.; Liu, X-Y. Role of microRNAs in stroke and poststroke depression. Sci. World J., 2013, 2013, 459692.
[http://dx.doi.org/10.1155/2013/459692] [PMID: 24363618]
[83]
Ultimo, S.; Zauli, G.; Martelli, A.M.; Vitale, M.; McCubrey, J.A.; Capitani, S.; Neri, L.M. Cardiovascular disease-related miRNAs expression: Potential role as biomarkers and effects of training exercise. Oncotarget, 2018, 9(24), 17238-17254.
[http://dx.doi.org/10.18632/oncotarget.24428] [PMID: 29682219]
[84]
Long, G.; Wang, F.; Li, H.; Yin, Z.; Sandip, C.; Lou, Y.; Wang, Y.; Chen, C.; Wang, D.W. Circulating miR-30a, miR-126 and let-7b as biomarker for ischemic stroke in humans. BMC Neurol., 2013, 13, 178.
[http://dx.doi.org/10.1186/1471-2377-13-178] [PMID: 24237608]
[85]
Galea, I. The blood-brain barrier in systemic infection and inflammation. Cell. Mol. Immunol., 2021, 18(11), 2489-2501.
[http://dx.doi.org/10.1038/s41423-021-00757-x] [PMID: 34594000]
[86]
Faraoni, I.; Antonetti, F.R.; Cardone, J.; Bonmassar, E. miR-155 gene: A typical multifunctional microRNA. Biochim. Biophys. Acta (BBA), 2009, 1792(6), 497-505.
[http://dx.doi.org/10.1016/j.bbadis.2009.02.013]
[87]
Jiang, T.; Zhou, S.; Li, X.; Song, J.; An, T.; Huang, X.; Ping, X.; Wang, L. MicroRNA-155 induces protection against cerebral ischemia/reperfusion injury through regulation of the Notch pathway in vivo. Exp. Ther. Med., 2019, 18(1), 605-613.
[http://dx.doi.org/10.3892/etm.2019.7590] [PMID: 31258696]
[88]
Mann, M.; Mehta, A.; Zhao, J.L.; Lee, K.; Marinov, G.K.; Garcia-Flores, Y.; Lu, L.F.; Rudensky, A.Y.; Baltimore, D. An NF-κB-microRNA regulatory network tunes macrophage inflammatory responses. Nat. Commun., 2017, 8(1), 851.
[http://dx.doi.org/10.1038/s41467-017-00972-z] [PMID: 29021573]
[89]
Zhang, L.; Liu, C.; Huang, C.; Xu, X.; Teng, J. miR-155 knockdown protects against cerebral ischemia and reperfusion injury by targeting MafB. BioMed Res. Int., 2020, 2020, 6458204.
[http://dx.doi.org/10.1155/2020/6458204] [PMID: 32090104]
[90]
Roitbak, T. Silencing a multifunctional microRNA is beneficial for stroke recovery. Front. Mol. Neurosci., 2018, 11, 58.
[http://dx.doi.org/10.3389/fnmol.2018.00058] [PMID: 29527155]
[91]
Sun, Y.; Liu, R.; Xia, X.; Xing, L.; Yang, C.; Jiang, J. Large-scale profiling of lncRNAs in human non-nucleated cells: Implications in cell function and disease. SSRN Electron. J., 2018. Available at SSRN 3295647
[http://dx.doi.org/10.2139/ssrn.3295649]
[92]
Xu, G.; Zhang, W.; Wang, Z.; Chen, M.; Shi, B. Matrine regulates H2O2-induced oxidative stress through long non- coding RNA HOTAIR/miR-106b-5p axis via AKT and STAT3 pathways. Biosci. Rep., 2020, 40(5), BSR20192560.
[http://dx.doi.org/10.1042/BSR20192560] [PMID: 32395744]
[93]
Sun, C.; Huang, L.; Li, Z.; Leng, K.; Xu, Y.; Jiang, X.; Cui, Y. Long non-coding RNA MIAT in development and disease: A new player in an old game. J. Biomed. Sci., 2018, 25(1), 23.
[http://dx.doi.org/10.1186/s12929-018-0427-3] [PMID: 29534728]
[94]
Wang, X-M.; Li, X-M.; Song, N.; Zhai, H.; Gao, X-M.; Yang, Y-N. Long non-coding RNAs H19, MALAT1 and MIAT as potential novel biomarkers for diagnosis of acute myocardial infarction. Biomed. Pharmacother., 2019, 118, 109208.
[http://dx.doi.org/10.1016/j.biopha.2019.109208] [PMID: 31302423]
[95]
Collins, L.; Binder, P.; Chen, H.; Wang, X. Regulation of long non-coding RNAs and MicroRNAs in heart disease: Insight into mechanisms and therapeutic approaches. Front. Physiol., 2020, 11, 798.
[http://dx.doi.org/10.3389/fphys.2020.00798] [PMID: 32754048]
[96]
Chen, C.; Tang, Y.; Sun, H.; Lin, X.; Jiang, B. The roles of long noncoding RNAs in myocardial pathophysiology. Biosci. Rep., 2019, 39(11), BSR20190966.
[http://dx.doi.org/10.1042/BSR20190966] [PMID: 31694052]
[97]
Zhang, X.; Hamblin, M.H.; Yin, K-J. The long noncoding RNA Malat1: Its physiological and pathophysiological functions. RNA Biol., 2017, 14(12), 1705-1714.
[http://dx.doi.org/10.1080/15476286.2017.1358347] [PMID: 28837398]
[98]
Hu, H.; Wu, J.; Li, D.; Zhou, J.; Yu, H.; Ma, L. Knockdown of lncRNA MALAT1 attenuates acute myocardial infarction through miR-320-Pten axis. Biomed. Pharmacother., 2018, 106, 738-746.
[http://dx.doi.org/10.1016/j.biopha.2018.06.122] [PMID: 29990866]
[99]
Sun, R.; Zhang, L. Long non-coding RNA MALAT1 regulates cardiomyocytes apoptosis after hypoxia/reperfusion injury via modulating miR-200a-3p/PDCD4 axis. Biomed. Pharmacother., 2019, 111, 1036-1045.
[http://dx.doi.org/10.1016/j.biopha.2018.12.122] [PMID: 30841417]
[100]
Hu, H.; Wu, J.; Yu, X.; Zhou, J.; Yu, H.; Ma, L. Long non- coding RNA MALAT1 enhances the apoptosis of cardiomyocytes through autophagy inhibition by regulating TSC2-mTOR signaling. Biol. Res., 2019, 52(1), 58.
[http://dx.doi.org/10.1186/s40659-019-0265-0] [PMID: 31783925]
[101]
Askarian-Amiri, M.E.; Crawford, J.; French, J.D.; Smart, C.E.; Smith, M.A.; Clark, M.B.; Ru, K.; Mercer, T.R.; Thompson, E.R.; Lakhani, S.R.; Vargas, A.C.; Campbell, I.G.; Brown, M.A.; Dinger, M.E.; Mattick, J.S. SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer. RNA, 2011, 17(5), 878-891.
[http://dx.doi.org/10.1261/rna.2528811] [PMID: 21460236]
[102]
Kolenda, T.; Guglas, K.; Kopczyńska, M.; Teresiak, A.; Bliźniak, R.; Mackiewicz, A.; Lamperska, K.; Mackiewicz, J. Oncogenic role of ZFAS1 lncRNA in head and neck squamous cell carcinomas. Cells, 2019, 8(4), 366.
[http://dx.doi.org/10.3390/cells8040366] [PMID: 31010087]
[103]
Zhang, Y.; Jiao, L.; Sun, L.; Li, Y.; Gao, Y.; Xu, C.; Shao, Y.; Li, M.; Li, C.; Lu, Y.; Pan, Z.; Xuan, L.; Zhang, Y.; Li, Q.; Yang, R.; Zhuang, Y.; Zhang, Y.; Yang, B. LncRNA ZFAS1 as a SERCA2a Inhibitor to Cause Intracellular Ca2+ overload and contractile dysfunction in a mouse model of myocardial infarction. Circ. Res., 2018, 122(10), 1354-1368.
[http://dx.doi.org/10.1161/CIRCRESAHA.117.312117] [PMID: 29475982]
[104]
Kong, Y.; Hsieh, C-H.; Alonso, L.C. ANRIL: A lncRNA at the CDKN2A/B locus with roles in cancer and metabolic disease. Front. Endocrinol. (Lausanne), 2018, 9(405), 405.
[http://dx.doi.org/10.3389/fendo.2018.00405] [PMID: 30087655]
[105]
Papait, R.; Kunderfranco, P.; Stirparo, G.G.; Latronico, M.V.G.; Condorelli, G. Long noncoding RNA: A new player of heart failure? J. Cardiovasc. Transl. Res., 2013, 6(6), 876-883.
[http://dx.doi.org/10.1007/s12265-013-9488-6] [PMID: 23835777]
[106]
Holdt, L.M.; Beutner, F.; Scholz, M.; Gielen, S.; Gäbel, G.; Bergert, H.; Schuler, G.; Thiery, J.; Teupser, D. ANRIL expression is associated with atherosclerosis risk at chromosome 9p21. Arterioscler. Thromb. Vasc. Biol., 2010, 30(3), 620-627.
[http://dx.doi.org/10.1161/ATVBAHA.109.196832] [PMID: 20056914]
[107]
Hannou, S.A.; Wouters, K.; Paumelle, R.; Staels, B. Functional genomics of the CDKN2A/B locus in cardiovascular and metabolic disease: What have we learned from GWASs? Trends Endocrinol. Metab., 2015, 26(4), 176-184.
[http://dx.doi.org/10.1016/j.tem.2015.01.008] [PMID: 25744911]
[108]
Dai, W.; Lee, D. Interfering with long chain noncoding RNA ANRIL expression reduces heart failure in rats with diabetes by inhibiting myocardial oxidative stress. J. Cell. Biochem., 2019, 120(10), 18446-18456.
[http://dx.doi.org/10.1002/jcb.29162] [PMID: 31211466]
[109]
Zhou, X.; Han, X.; Wittfeldt, A.; Sun, J.; Liu, C.; Wang, X.; Gan, L.M.; Cao, H.; Liang, Z. Long non-coding RNA ANRIL regulates inflammatory responses as a novel component of NF-κB pathway. RNA Biol., 2016, 13(1), 98-108.
[http://dx.doi.org/10.1080/15476286.2015.1122164] [PMID: 26618242]
[110]
Murray, R.; Bryant, J.; Titcombe, P.; Barton, S.J.; Inskip, H.; Harvey, N.C.; Cooper, C.; Lillycrop, K.; Hanson, M.; Godfrey, K.M. DNA methylation at birth within the promoter of ANRIL predicts markers of cardiovascular risk at 9 years. Clin. Epigenetics, 2016, 8(1), 90.
[http://dx.doi.org/10.1186/s13148-016-0259-5] [PMID: 27594927]
[111]
Bai, Y.; Nie, S.; Jiang, G.; Zhou, Y.; Zhou, M.; Zhao, Y.; Li, S.; Wang, F.; Lv, Q.; Huang, Y.; Yang, Q.; Li, Q.; Li, Y.; Xia, Y.; Liu, Y.; Liu, J.; Qian, J.; Li, B.; Wu, G.; Wu, Y.; Wang, B.; Cheng, X.; Yang, Y.; Ke, T.; Li, H.; Ren, X.; Ma, X.; Liao, Y.; Xu, C.; Tu, X.; Wang, Q.K. Regulation of CARD8 expression by ANRIL and association of CARD8 single nucleotide polymorphism rs2043211 (p.C10X) with ischemic stroke. Stroke, 2014, 45(2), 383-388.
[http://dx.doi.org/10.1161/STROKEAHA.113.003393] [PMID: 24385277]
[112]
Cheng, M.; An, S.; Li, J. CDKN2B-AS may indirectly regulate coronary artery disease-associated genes via targeting miR-92a. Gene, 2017, 629, 101-107.
[http://dx.doi.org/10.1016/j.gene.2017.07.070] [PMID: 28760552]
[113]
Rinn, J.L.; Kertesz, M.; Wang, J.K.; Squazzo, S.L.; Xu, X.; Brugmann, S.A.; Goodnough, L.H.; Helms, J.A.; Farnham, P.J.; Segal, E.; Chang, H.Y. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell, 2007, 129(7), 1311-1323.
[http://dx.doi.org/10.1016/j.cell.2007.05.022] [PMID: 17604720]
[114]
He, S.; Liu, S.; Zhu, H. The sequence, structure and evolutionary features of HOTAIR in mammals. BMC Evol. Biol., 2011, 11(1), 102.
[http://dx.doi.org/10.1186/1471-2148-11-102] [PMID: 21496275]
[115]
Davidovich, C.; Zheng, L.; Goodrich, K.J.; Cech, T.R. Promiscuous RNA binding by Polycomb repressive complex 2. Nat. Struct. Mol. Biol., 2013, 20(11), 1250-1257.
[http://dx.doi.org/10.1038/nsmb.2679] [PMID: 24077223]
[116]
Avazpour, N.; Hajjari, M.; Yazdankhah, S.; Sahni, A.; Foroughmand, A.M. Circulating HOTAIR RNA is potentially up-regulated in coronary artery disease. Genom. Inform., 2018, 16(4), e25.
[117]
Jiang, Y.; Mo, H.; Luo, J.; Zhao, S.; Liang, S.; Zhang, M.; Yuan, J. HOTAIR is a potential novel biomarker in patients with congenital heart diseases. BioMed Res. Int., 2018, 2018, 2850657.
[http://dx.doi.org/10.1155/2018/2850657] [PMID: 29707567]
[118]
Wu, H.; Liu, J.; Li, W.; Liu, G.; Li, Z. LncRNA-HOTAIR promotes TNF-α production in cardiomyocytes of LPS-induced sepsis mice by activating NF-κB pathway. Biochem. Biophys. Res. Commun., 2016, 471(1), 240-246.
[http://dx.doi.org/10.1016/j.bbrc.2016.01.117] [PMID: 26806307]
[119]
Akbari, M.; Yassaee, F.; Aminbeidokhti, M.; Abedin-Do, A.; Mirfakhraie, R. LncRNA SRA1 may play a role in the uterine leiomyoma tumor growth regarding the MED12 mutation pattern. Int. J. Womens Health, 2019, 11, 495-500.
[http://dx.doi.org/10.2147/IJWH.S211632] [PMID: 31507331]
[120]
Sheng, L.; Ye, L.; Zhang, D.; Cawthorn, W.P.; Xu, B. New insights into the long non-coding RNA SRA: Physiological functions and mechanisms of action. Front. Med. (Lausanne), 2018, 5(244), 244.
[http://dx.doi.org/10.3389/fmed.2018.00244] [PMID: 30238005]
[121]
Lanz, R.B.; Razani, B.; Goldberg, A.D.; O’Malley, B.W. Distinct RNA motifs are important for coactivation of steroid hormone receptors by steroid receptor RNA activator (SRA). Proc. Natl. Acad. Sci. USA, 2002, 99(25), 16081-16086.
[http://dx.doi.org/10.1073/pnas.192571399] [PMID: 12444263]
[122]
Friedrichs, F.; Zugck, C.; Rauch, G-J.; Ivandic, B.; Weichenhan, D.; Müller-Bardorff, M.; Meder, B.; El Mokhtari, N.E.; Regitz-Zagrosek, V.; Hetzer, R.; Schäfer, A.; Schreiber, S.; Chen, J.; Neuhaus, I.; Ji, R.; Siemers, N.O.; Frey, N.; Rottbauer, W.; Katus, H.A.; Stoll, M. HBEGF, SRA1, and IK: Three cosegregating genes as determinants of cardiomyopathy. Genome Res., 2009, 19(3), 395-403.
[http://dx.doi.org/10.1101/gr.076653.108] [PMID: 19064678]
[123]
Biondi, B. Mechanisms in endocrinology: Heart failure and thyroid dysfunction. Eur. J. Endocrinol., 2012, 167(5), 609-618.
[http://dx.doi.org/10.1530/EJE-12-0627] [PMID: 22956554]
[124]
Xu, B.; Koenig, R.J. An RNA-binding domain in the thyroid hormone receptor enhances transcriptional activation. J. Biol. Chem., 2004, 279(32), 33051-33056.
[http://dx.doi.org/10.1074/jbc.M404930200] [PMID: 15180993]
[125]
Lanz, R.B.; Chua, S.S.; Barron, N.; Söder, B.M.; DeMayo, F.; O’Malley, B.W. Steroid receptor RNA activator stimulates proliferation as well as apoptosis in vivo. Mol. Cell. Biol., 2003, 23(20), 7163-7176.
[http://dx.doi.org/10.1128/MCB.23.20.7163-7176.2003] [PMID: 14517287]
[126]
Zhang, S.; Gao, S.; Wang, Y.; Jin, P.; Lu, F. lncRNA SRA1 Promotes the activation of cardiac myofibroblasts through negative regulation of miR-148b. DNA Cell Biol., 2019, 38(4), 385-394.
[http://dx.doi.org/10.1089/dna.2018.4358] [PMID: 30694702]
[127]
Dong, P.; Xiong, Y.; Yue, J.; Hanley, S.J.B.; Kobayashi, N.; Todo, Y.; Watari, H. Long non-coding RNA NEAT1: A novel target for diagnosis and therapy in human tumors. Front. Genet., 2018, 9(471), 471.
[http://dx.doi.org/10.3389/fgene.2018.00471] [PMID: 30374364]
[128]
Li, P.; Duan, S.; Fu, A. Long noncoding RNA NEAT1 correlates with higher disease risk, worse disease condition, decreased miR-124 and miR-125a and predicts poor recurrence-free survival of acute ischemic stroke. J. Clin. Lab. Anal., 2020, 34(2), e23056.
[http://dx.doi.org/10.1002/jcla.23056] [PMID: 31721299]
[129]
Wang, L.; Xia, J-W.; Ke, Z-P.; Zhang, B-H. Blockade of NEAT1 represses inflammation response and lipid uptake via modulating miR-342-3p in human macrophages THP-1 cells. J. Cell. Physiol., 2019, 234(4), 5319-5326.
[http://dx.doi.org/10.1002/jcp.27340] [PMID: 30259979]
[130]
Du, X-J.; Wei, J.; Tian, D.; Yan, C.; Hu, P.; Wu, X.; Yang, W.; Hu, X. NEAT1 promotes myocardial ischemia-reperfusion injury via activating the MAPK signaling pathway. J. Cell. Physiol., 2019, 234(10), 18773-18780.
[http://dx.doi.org/10.1002/jcp.28516] [PMID: 30950059]
[131]
Zhang, P.; Cao, L.; Zhou, R.; Yang, X.; Wu, M. The lncRNA Neat1 promotes activation of inflammasomes in macrophages. Nat. Commun., 2019, 10(1), 1495.
[http://dx.doi.org/10.1038/s41467-019-09482-6] [PMID: 30940803]
[132]
Wang, P.; Zhang, N.; Liang, J.; Li, J.; Han, S.; Li, J. Micro-RNA-30a regulates ischemia-induced cell death by targeting heat shock protein HSPA5 in primary cultured cortical neurons and mouse brain after stroke. J. Neurosci. Res., 2015, 93(11), 1756-1768.
[http://dx.doi.org/10.1002/jnr.23637] [PMID: 26301516]
[133]
Guo, D.; Ma, J.; Yan, L.; Li, T.; Li, Z.; Han, X.; Shui, S. Down-regulation of Lncrna MALAT1 attenuates neuronal cell death through suppressing Beclin1-dependent autophagy by regulating Mir-30a in cerebral ischemic stroke. Cell. Physiol. Biochem., 2017, 43(1), 182-194.
[http://dx.doi.org/10.1159/000480337] [PMID: 28854438]
[134]
Zhang, T.; Wang, H.; Li, Q.; Fu, J.; Huang, J.; Zhao, Y. MALAT1 activates the P53 signaling pathway by regulating MDM2 to promote ischemic stroke. Cell. Physiol. Biochem., 2018, 50(6), 2216-2228.
[http://dx.doi.org/10.1159/000495083] [PMID: 30419554]
[135]
Wang, H.; Zheng, X.; Jin, J.; Zheng, L.; Guan, T.; Huo, Y.; Xie, S.; Wu, Y.; Chen, W. LncRNA MALAT1 silencing protects against cerebral ischemia-reperfusion injury through miR-145 to regulate AQP4. J. Biomed. Sci., 2020, 27(1), 40.
[http://dx.doi.org/10.1186/s12929-020-00635-0] [PMID: 32138732]
[136]
Salemi, M.; Marchese, G.; Cordella, A.; Cannarella, R.; Barone, C.; Salluzzo, M.G.; Calogero, A.E.; Romano, C. Long non-coding RNA GAS5 expression in patients with Down syndrome. Int. J. Med. Sci., 2020, 17(10), 1315-1319.
[http://dx.doi.org/10.7150/ijms.45386] [PMID: 32624686]
[137]
Zhou, Y.; Chen, B. GAS5 mediated regulation of cell signaling (Review). Mol. Med. Rep., 2020, 22(4), 3049-3056.
[PMID: 32945519]
[138]
Wu, Y.; Gao, Z.; Zhang, J. Transcription factor E2F1 aggravates neurological injury in ischemic stroke via microRNA-122-targeted sprouty2. Neuropsychiatr. Dis. Treat., 2020, 16, 2633-2647.
[http://dx.doi.org/10.2147/NDT.S271320] [PMID: 33177827]
[139]
MacManus, J.P.; Jian, M.; Preston, E.; Rasquinha, I.; Webster, J.; Zurakowski, B. Absence of the transcription factor E2F1 attenuates brain injury and improves behavior after focal ischemia in mice. J. Cereb. Blood Flow Metab., 2003, 23(9), 1020-1028.
[http://dx.doi.org/10.1097/01.WCB.0000084249.20114.FA] [PMID: 12973018]
[140]
Buller, B.; Liu, X.; Wang, X.; Zhang, R.L.; Zhang, L.; Hozeska-Solgot, A.; Chopp, M.; Zhang, Z.G. MicroRNA-21 protects neurons from ischemic death. FEBS J., 2010, 277(20), 4299-4307.
[http://dx.doi.org/10.1111/j.1742-4658.2010.07818.x] [PMID: 20840605]
[141]
Yang, L.; Wang, B.; Zhou, Q.; Wang, Y.; Liu, X.; Liu, Z.; Zhan, Z. MicroRNA-21 prevents excessive inflammation and cardiac dysfunction after myocardial infarction through targeting KBTBD7. Cell Death Dis., 2018, 9(7), 769.
[http://dx.doi.org/10.1038/s41419-018-0805-5] [PMID: 29991775]
[142]
Yu, X.; Li, Z. Long non-coding RNA growth arrest-specific transcript 5 in tumor biology. Oncol. Lett., 2015, 10(4), 1953-1958.
[http://dx.doi.org/10.3892/ol.2015.3553] [PMID: 26622780]
[143]
Maass, P.G.; Glažar, P.; Memczak, S.; Dittmar, G.; Hollfinger, I.; Schreyer, L.; Sauer, A.V.; Toka, O.; Aiuti, A.; Luft, F.C.; Rajewsky, N. A map of human circular RNAs in clinically relevant tissues. J. Mol. Med. (Berl.), 2017, 95(11), 1179-1189.
[http://dx.doi.org/10.1007/s00109-017-1582-9] [PMID: 28842720]
[144]
Guo, Z.; Cao, Q.; Zhao, Z.; Song, C. Biogenesis, features, functions, and disease relationships of a specific circular RNA: CDR1as. Aging Dis., 2020, 11(4), 1009-1020.
[http://dx.doi.org/10.14336/AD.2019.0920] [PMID: 32765960]
[145]
Barrett, S.P.; Parker, K.R.; Horn, C.; Mata, M.; Salzman, J. ciRS-7 exonic sequence is embedded in a long non-coding RNA locus. PLoS Genet., 2017, 13(12), e1007114.
[http://dx.doi.org/10.1371/journal.pgen.1007114] [PMID: 29236709]
[146]
Piwecka, M.; Glažar, P.; Hernandez-Miranda, L.R.; Memczak, S.; Wolf, S.A.; Rybak-Wolf, A.; Filipchyk, A.; Klironomos, F.; Cerda Jara, C.A.; Fenske, P.; Trimbuch, T.; Zywitza, V.; Plass, M.; Schreyer, L.; Ayoub, S.; Kocks, C.; Kühn, R.; Rosenmund, C.; Birchmeier, C.; Rajewsky, N. Loss of a mammalian circular RNA locus causes miRNA deregulation and affects brain function. Science, 2017, 357(6357), eaam8526.
[http://dx.doi.org/10.1126/science.aam8526] [PMID: 28798046]
[147]
Altesha, M.A.; Ni, T.; Khan, A.; Liu, K.; Zheng, X. Circular RNA in cardiovascular disease. J. Cell. Physiol., 2019, 234(5), 5588-5600.
[http://dx.doi.org/10.1002/jcp.27384] [PMID: 30341894]
[148]
Zhang, Y.; Sun, L.; Xuan, L.; Pan, Z.; Li, K.; Liu, S.; Huang, Y.; Zhao, X.; Huang, L.; Wang, Z.; Hou, Y.; Li, J.; Tian, Y.; Yu, J.; Han, H.; Liu, Y.; Gao, F.; Zhang, Y.; Wang, S.; Du, Z.; Lu, Y.; Yang, B. Reciprocal changes of circulating long non-coding RNAs ZFAS1 and CDR1AS predict acute myocardial infarction. Sci. Rep., 2016, 6(1), 22384.
[http://dx.doi.org/10.1038/srep22384] [PMID: 26928231]
[149]
Geng, H-H.; Li, R.; Su, Y-M.; Xiao, J.; Pan, M.; Cai, X-X.; Ji, X.P. The circular RNA Cdr1as promotes myocardial infarction by mediating the regulation of miR-7a on its target genes expression. PLoS One, 2016, 11(3), e0151753.
[http://dx.doi.org/10.1371/journal.pone.0151753] [PMID: 26998750]
[150]
Chen, C.; Shen, H.; Huang, Q.; Li, Q. The circular RNA CDR1as regulates the proliferation and apoptosis of human cardiomyocytes through the miR-135a/HMOX1 and miR-135b/HMOX1 axes. Genet. Test. Mol. Biomarkers, 2020, 24(9), 537-548.
[http://dx.doi.org/10.1089/gtmb.2020.0034] [PMID: 32762552]
[151]
Zhang, L.; Li, Y.; Liu, W.; Li, H.; Zhu, Z. Analysis of the complex interaction of CDR1as-miRNA-protein and detection of its novel role in melanoma. Oncol. Lett., 2018, 16(1), 1219-1225.
[http://dx.doi.org/10.3892/ol.2018.8700] [PMID: 29963195]
[152]
Burd, C.E.; Jeck, W.R.; Liu, Y.; Sanoff, H.K.; Wang, Z.; Sharpless, N.E. Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk. PLoS Genet., 2010, 6(12), e1001233.
[http://dx.doi.org/10.1371/journal.pgen.1001233] [PMID: 21151960]
[153]
Zhang, S.; Wang, W.; Wu, X.; Zhou, X. Regulatory roles of circular RNAs in coronary artery disease. Mol. Ther. Nucleic Acids, 2020, 21, 172-179.
[http://dx.doi.org/10.1016/j.omtn.2020.05.024] [PMID: 32585625]
[154]
Roberts, D.E.; Matsuda, T.; Bose, R. Molecular and functional characterization of the human platelet Na+ /Ca2+ exchangers. Br. J. Pharmacol., 2012, 165(4), 922-936.
[http://dx.doi.org/10.1111/j.1476-5381.2011.01600.x] [PMID: 21790537]
[155]
Li, M.; Ding, W.; Tariq, M.A.; Chang, W.; Zhang, X.; Xu, W.; Hou, L.; Wang, Y.; Wang, J. A circular transcript of ncx1 gene mediates ischemic myocardial injury by targeting miR-133a-3p. Theranostics, 2018, 8(21), 5855-5869.
[http://dx.doi.org/10.7150/thno.27285] [PMID: 30613267]
[156]
Lim, T.B.; Aliwarga, E.; Luu, T.D.A.; Li, Y.P.; Ng, S.L.; Annadoray, L.; Sian, S.; Ackers-Johnson, M.A.; Foo, R.S. Targeting the highly abundant circular RNA circSlc8a1 in cardiomyocytes attenuates pressure overload induced hypertrophy. Cardiovasc. Res., 2019, 115(14), 1998-2007.
[http://dx.doi.org/10.1093/cvr/cvz130] [PMID: 31114845]
[157]
Mortuza, G.B.; Hermida, D.; Pedersen, A-K.; Segura-Bayona, S.; López-Méndez, B.; Redondo, P.; Rüther, P.; Pozdnyakova, I.; Garrote, A.M.; Muñoz, I.G.; Villamor-Payà, M.; Jauset, C.; Olsen, J.V.; Stracker, T.H.; Montoya, G. Molecular basis of tousled-like kinase 2 activation. Nat. Commun., 2018, 9(1), 2535.
[http://dx.doi.org/10.1038/s41467-018-04941-y] [PMID: 29955062]
[158]
Mehta, S.L.; Dempsey, R.J.; Vemuganti, R. Role of circular RNAs in brain development and CNS diseases. Prog. Neurobiol., 2020, 186, 101746.
[http://dx.doi.org/10.1016/j.pneurobio.2020.101746] [PMID: 31931031]
[159]
Wu, F.; Han, B.; Wu, S.; Yang, L.; Leng, S.; Li, M.; Liao, J.; Wang, G.; Ye, Q.; Zhang, Y.; Chen, H.; Chen, X.; Zhong, M.; Xu, Y.; Liu, Q.; Zhang, J.H.; Yao, H. Circular RNA aggravates neuronal injury and neurological deficits after ischemic stroke via miR-335-3p/TIPARP. J. Neurosci., 2019, 39(37), 7369-7393.
[http://dx.doi.org/10.1523/JNEUROSCI.0299-19.2019] [PMID: 31311824]
[160]
Zheng, Q.; Bao, C.; Guo, W.; Li, S.; Chen, J.; Chen, B.; Luo, Y.; Lyu, D.; Li, Y.; Shi, G.; Liang, L.; Gu, J.; He, X.; Huang, S. Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs. Nat. Commun., 2016, 7(1), 11215.
[http://dx.doi.org/10.1038/ncomms11215] [PMID: 27050392]
[161]
Wang, Y.; Huang, J.; Ma, Y.; Tang, G.; Liu, Y.; Chen, X.; Zhang, Z.; Zeng, L.; Wang, Y.; Ouyang, Y.B.; Yang, G.Y. MicroRNA-29b is a therapeutic target in cerebral ischemia associated with aquaporin 4. J. Cereb. Blood Flow Metab., 2015, 35(12), 1977-1984.
[http://dx.doi.org/10.1038/jcbfm.2015.156] [PMID: 26126866]
[162]
Bazan, H.A.; Hatfield, S.A.; Brug, A.; Brooks, A.J.; Lightell, D.J., Jr; Woods, T.C. Carotid plaque rupture is accompanied by an increase in the ratio of serum circR-284 to miR-221 levels. Circ. Cardiovasc. Genet., 2017, 10(4), e001720.
[http://dx.doi.org/10.1161/CIRCGENETICS.117.001720] [PMID: 28779016]

Rights & Permissions Print Cite
Article Metrics
24
1
© 2024 Bentham Science Publishers | Privacy Policy